Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| connective tissue cell | 5 studies | 23% ± 4% | |
| fibroblast | 5 studies | 23% ± 9% | |
| epithelial cell | 4 studies | 36% ± 14% | |
| basal cell | 4 studies | 27% ± 7% | |
| hematopoietic precursor cell | 3 studies | 33% ± 14% | |
| erythroblast | 3 studies | 32% ± 7% | |
| macrophage | 3 studies | 18% ± 2% | |
| dendritic cell | 3 studies | 26% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 100% | 947.24 | 1809 / 1809 | 100% | 125.09 | 472 / 472 |
| uterus | 100% | 681.79 | 170 / 170 | 100% | 134.11 | 457 / 459 |
| pancreas | 100% | 633.96 | 328 / 328 | 99% | 78.99 | 177 / 178 |
| prostate | 100% | 585.17 | 245 / 245 | 98% | 78.17 | 494 / 502 |
| ovary | 100% | 763.67 | 180 / 180 | 98% | 63.93 | 422 / 430 |
| bladder | 100% | 709.48 | 21 / 21 | 98% | 130.63 | 494 / 504 |
| thymus | 100% | 426.96 | 652 / 653 | 97% | 65.56 | 585 / 605 |
| lung | 99% | 449.29 | 574 / 578 | 96% | 105.03 | 1111 / 1155 |
| breast | 100% | 571.81 | 459 / 459 | 95% | 71.62 | 1059 / 1118 |
| intestine | 100% | 512.96 | 965 / 966 | 93% | 129.41 | 490 / 527 |
| adrenal gland | 100% | 738.56 | 258 / 258 | 89% | 47.99 | 204 / 230 |
| stomach | 100% | 417.02 | 359 / 359 | 85% | 88.21 | 242 / 286 |
| brain | 85% | 256.51 | 2233 / 2642 | 99% | 60.50 | 700 / 705 |
| kidney | 100% | 556.76 | 89 / 89 | 80% | 35.03 | 719 / 901 |
| esophagus | 100% | 592.09 | 1444 / 1445 | 75% | 31.89 | 137 / 183 |
| liver | 98% | 272.44 | 221 / 226 | 77% | 46.29 | 312 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 151.58 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 251.51 | 29 / 29 |
| spleen | 100% | 598.63 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 98.41 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 176.17 | 1 / 1 |
| adipose | 100% | 507.51 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 335.11 | 1317 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 296.09 | 787 / 803 | 0% | 0 | 0 / 0 |
| heart | 91% | 231.91 | 780 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 86% | 623.01 | 800 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006364 | Biological process | rRNA processing |
| GO_0009303 | Biological process | rRNA transcription |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0005730 | Cellular component | nucleolus |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| GO_0042393 | Molecular function | histone binding |
| GO_0003682 | Molecular function | chromatin binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | NPM3 |
| Protein name | Nucleoplasmin-3 |
| Synonyms | |
| Description | FUNCTION: Plays a role in the regulation of diverse cellular processes such as ribosome biogenesis, chromatin remodeling or protein chaperoning . Modulates the histone chaperone function and the RNA-binding activity of nucleolar phosphoprotein B23/NPM . Efficiently mediates chromatin remodeling when included in a pentamer containing NPM3 and NPM . . |
| Accessions | ENST00000370110.6 O75607 |
